Neil Iyengar

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Pfizer
    Topic:
    Breast Cancer
    Date added:
    09/07/2024
    Date updated:
    09/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Novartis
    Topic:
    Breast Cancer
    Date added:
    09/07/2024
    Date updated:
    09/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Genentech/Roche
    Topic:
    Breast Cancer
    Date added:
    09/07/2024
    Date updated:
    09/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Seattle Genetics
    Topic:
    Breast Cancer
    Date added:
    09/07/2024
    Date updated:
    09/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Astra Zeneca
    Topic:
    Breast Cancer
    Date added:
    09/07/2024
    Date updated:
    09/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Gilead
    Topic:
    Breast Cancer
    Date added:
    09/07/2024
    Date updated:
    09/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Menarini-Stemline
    Topic:
    Breast Cancer
    Date added:
    09/07/2024
    Date updated:
    09/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Daichii-Sankyo
    Topic:
    Breast Cancer
    Date added:
    09/07/2024
    Date updated:
    09/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    TerSera Therapeutics
    Topic:
    Breast Cancer
    Date added:
    09/07/2024
    Date updated:
    09/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    SynDevRx
    Topic:
    Breast Cancer
    Date added:
    09/07/2024
    Date updated:
    09/07/2024

Pages

Return to 4th Binaytara Precision Oncology Summit: Current Standards and Emerging Therapies